Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Blood culture-negative infective endocarditis: a worse outcome? Results from a large multicentre retrospective Spanish cohort study.
Suardi LR, de Alarcón A, García MV, Ciezar AP, Hidalgo Tenorio C, Martinez-Marcos FJ, Concejo-Martínez E, De la Torre Lima J, Vinuesa García D, Luque Márquez R, Ojeda G, Reguera Iglesias JM, Lomas JM, Lopez-Cortes LE; Grupo para el Estudio de las Infecciones Cardiovasculares de la Sociedad Andaluza de Enfermedades Infecciosas (GEICV-SAEI). Suardi LR, et al. Infect Dis (Lond). 2021 Oct;53(10):755-763. doi: 10.1080/23744235.2021.1925342. Epub 2021 May 26. Infect Dis (Lond). 2021. PMID: 34038316
Increased CD4/CD8 ratio as a risk factor for critical illness in coronavirus disease 2019 (COVID-19): a retrospective multicentre study.
Pallotto C, Suardi LR, Esperti S, Tarquini R, Grifoni E, Meini S, Valoriani A, Di Martino S, Cei F, Sisti E, Piani F, Botta A, Salomoni E, Baragli F, Blanc P. Pallotto C, et al. Among authors: suardi lr. Infect Dis (Lond). 2020 Sep;52(9):675-677. doi: 10.1080/23744235.2020.1778178. Epub 2020 Jun 16. Infect Dis (Lond). 2020. PMID: 32543971 No abstract available.
Risk factors for non-invasive/invasive ventilatory support in patients with COVID-19 pneumonia: A retrospective study within a multidisciplinary approach.
Suardi LR, Pallotto C, Esperti S, Tazzioli E, Baragli F, Salomoni E, Botta A, Covani Frigieri F, Pazzi M, Stera C, Carlucci M, Papa R, Meconi T, Pavoni V, Blanc P. Suardi LR, et al. Int J Infect Dis. 2020 Nov;100:258-263. doi: 10.1016/j.ijid.2020.09.012. Epub 2020 Sep 11. Int J Infect Dis. 2020. PMID: 32920232 Free PMC article.
Real-world experience with meropenem/vaborbactam for the treatment of infections caused by ESBL-producing Enterobacterales and carbapenem-resistant Klebsiella pneumoniae.
Tiseo G, Galfo V, Riccardi N, Suardi LR, Pogliaghi M, Giordano C, Leonildi A, Barnini S, Falcone M. Tiseo G, et al. Among authors: suardi lr. Eur J Clin Microbiol Infect Dis. 2024 Feb 20. doi: 10.1007/s10096-024-04758-2. Online ahead of print. Eur J Clin Microbiol Infect Dis. 2024. PMID: 38376634
Efficacy of Bamlanivimab/Etesevimab and Casirivimab/Imdevimab in Preventing Progression to Severe COVID-19 and Role of Variants of Concern.
Falcone M, Tiseo G, Valoriani B, Barbieri C, Occhineri S, Mazzetti P, Vatteroni ML, Suardi LR, Riccardi N, Pistello M, Tacconi D, Menichetti F. Falcone M, et al. Among authors: suardi lr. Infect Dis Ther. 2021 Dec;10(4):2479-2488. doi: 10.1007/s40121-021-00525-4. Epub 2021 Aug 25. Infect Dis Ther. 2021. PMID: 34435337 Free PMC article.
Efficacy and Safety of Nirmatrelvir/Ritonavir, Molnupiravir, and Remdesivir in a Real-World Cohort of Outpatients with COVID-19 at High Risk of Progression: The PISA Outpatient Clinic Experience.
Tiseo G, Barbieri C, Galfo V, Occhineri S, Matucci T, Almerigogna F, Kalo J, Sponga P, Cesaretti M, Marchetti G, Forniti A, Caroselli C, Ferranti S, Pogliaghi M, Polidori M, Fabiani S, Verdenelli S, Tagliaferri E, Riccardi N, Suardi LR, Carmignani C, Batini S, Puccetti L, Iapoce R, Menichetti F, Falcone M. Tiseo G, et al. Among authors: suardi lr. Infect Dis Ther. 2023 Jan;12(1):257-271. doi: 10.1007/s40121-022-00729-2. Epub 2022 Nov 28. Infect Dis Ther. 2023. PMID: 36441485 Free PMC article.
28 results